nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—SHMT1—Podofilox—Teniposide—lymphatic system cancer	0.0697	0.709	CbGdCrCtD
Glycine—Blindness transient—Methotrexate—lymphatic system cancer	0.0453	0.0502	CcSEcCtD
Glycine—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.0361	0.04	CcSEcCtD
Glycine—SHMT1—Vinblastine—Vincristine—lymphatic system cancer	0.0285	0.29	CbGdCrCtD
Glycine—Encephalopathy—Carmustine—lymphatic system cancer	0.0278	0.0308	CcSEcCtD
Glycine—Coma—Fludarabine—lymphatic system cancer	0.0255	0.0283	CcSEcCtD
Glycine—Visual disturbance—Fludarabine—lymphatic system cancer	0.0214	0.0237	CcSEcCtD
Glycine—Dehydration—Fludarabine—lymphatic system cancer	0.0188	0.0209	CcSEcCtD
Glycine—Angina pectoris—Fludarabine—lymphatic system cancer	0.017	0.0189	CcSEcCtD
Glycine—Vertigo—Mechlorethamine—lymphatic system cancer	0.0169	0.0187	CcSEcCtD
Glycine—Coma—Carmustine—lymphatic system cancer	0.0163	0.0181	CcSEcCtD
Glycine—Coma—Vincristine—lymphatic system cancer	0.0156	0.0173	CcSEcCtD
Glycine—Thrombophlebitis—Carmustine—lymphatic system cancer	0.015	0.0166	CcSEcCtD
Glycine—Chills—Teniposide—lymphatic system cancer	0.0143	0.0159	CcSEcCtD
Glycine—Polyuria—Vincristine—lymphatic system cancer	0.0141	0.0156	CcSEcCtD
Glycine—Visual impairment—Fludarabine—lymphatic system cancer	0.0135	0.015	CcSEcCtD
Glycine—Hyponatraemia—Carmustine—lymphatic system cancer	0.013	0.0144	CcSEcCtD
Glycine—Encephalopathy—Methotrexate—lymphatic system cancer	0.0129	0.0143	CcSEcCtD
Glycine—Chills—Fludarabine—lymphatic system cancer	0.0126	0.0139	CcSEcCtD
Glycine—Hyponatraemia—Vincristine—lymphatic system cancer	0.0124	0.0138	CcSEcCtD
Glycine—Hyponatraemia—Mitoxantrone—lymphatic system cancer	0.0121	0.0134	CcSEcCtD
Glycine—Urinary retention—Vincristine—lymphatic system cancer	0.0118	0.013	CcSEcCtD
Glycine—Lung disorder—Methotrexate—lymphatic system cancer	0.0117	0.013	CcSEcCtD
Glycine—Dehydration—Vincristine—lymphatic system cancer	0.0115	0.0128	CcSEcCtD
Glycine—Oedema—Teniposide—lymphatic system cancer	0.0113	0.0126	CcSEcCtD
Glycine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0113	0.0125	CcSEcCtD
Glycine—Dehydration—Mitoxantrone—lymphatic system cancer	0.0112	0.0124	CcSEcCtD
Glycine—Tachycardia—Teniposide—lymphatic system cancer	0.011	0.0123	CcSEcCtD
Glycine—Hypotension—Teniposide—lymphatic system cancer	0.0106	0.0117	CcSEcCtD
Glycine—Convulsion—Fludarabine—lymphatic system cancer	0.0106	0.0117	CcSEcCtD
Glycine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0105	0.0117	CcSEcCtD
Glycine—Oedema—Fludarabine—lymphatic system cancer	0.00995	0.011	CcSEcCtD
Glycine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00976	0.0108	CcSEcCtD
Glycine—Chills—Bleomycin—lymphatic system cancer	0.00921	0.0102	CcSEcCtD
Glycine—Nausea—Mechlorethamine—lymphatic system cancer	0.00912	0.0101	CcSEcCtD
Glycine—Urticaria—Teniposide—lymphatic system cancer	0.00899	0.00997	CcSEcCtD
Glycine—Visual impairment—Carmustine—lymphatic system cancer	0.00864	0.00958	CcSEcCtD
Glycine—Pain—Fludarabine—lymphatic system cancer	0.00851	0.00943	CcSEcCtD
Glycine—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00835	0.00926	CcSEcCtD
Glycine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00834	0.00925	CcSEcCtD
Glycine—Diarrhoea—Teniposide—lymphatic system cancer	0.00775	0.00859	CcSEcCtD
Glycine—Coma—Methotrexate—lymphatic system cancer	0.00755	0.00838	CcSEcCtD
Glycine—Back pain—Carmustine—lymphatic system cancer	0.00755	0.00837	CcSEcCtD
Glycine—Chills—Mitoxantrone—lymphatic system cancer	0.00748	0.00829	CcSEcCtD
Glycine—Vision blurred—Carmustine—lymphatic system cancer	0.00735	0.00815	CcSEcCtD
Glycine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00733	0.00813	CcSEcCtD
Glycine—Oedema—Bleomycin—lymphatic system cancer	0.00729	0.00809	CcSEcCtD
Glycine—Back pain—Vincristine—lymphatic system cancer	0.0072	0.00799	CcSEcCtD
Glycine—Vomiting—Teniposide—lymphatic system cancer	0.0072	0.00798	CcSEcCtD
Glycine—Back pain—Mitoxantrone—lymphatic system cancer	0.00702	0.00778	CcSEcCtD
Glycine—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00693	0.00769	CcSEcCtD
Glycine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00684	0.00758	CcSEcCtD
Glycine—Polyuria—Methotrexate—lymphatic system cancer	0.00683	0.00758	CcSEcCtD
Glycine—Hypotension—Bleomycin—lymphatic system cancer	0.00682	0.00756	CcSEcCtD
Glycine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00681	0.00755	CcSEcCtD
Glycine—Convulsion—Carmustine—lymphatic system cancer	0.00676	0.0075	CcSEcCtD
Glycine—Nausea—Teniposide—lymphatic system cancer	0.00672	0.00746	CcSEcCtD
Glycine—Vertigo—Vincristine—lymphatic system cancer	0.00669	0.00742	CcSEcCtD
Glycine—Convulsion—Vincristine—lymphatic system cancer	0.00645	0.00716	CcSEcCtD
Glycine—Oedema—Carmustine—lymphatic system cancer	0.00637	0.00706	CcSEcCtD
Glycine—Visual disturbance—Methotrexate—lymphatic system cancer	0.00633	0.00702	CcSEcCtD
Glycine—Vomiting—Fludarabine—lymphatic system cancer	0.00633	0.00701	CcSEcCtD
Glycine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00628	0.00697	CcSEcCtD
Glycine—Pain—Bleomycin—lymphatic system cancer	0.00624	0.00692	CcSEcCtD
Glycine—Tachycardia—Carmustine—lymphatic system cancer	0.00621	0.00689	CcSEcCtD
Glycine—Oedema—Vincristine—lymphatic system cancer	0.00608	0.00674	CcSEcCtD
Glycine—Hypotension—Carmustine—lymphatic system cancer	0.00595	0.0066	CcSEcCtD
Glycine—Oedema—Mitoxantrone—lymphatic system cancer	0.00592	0.00656	CcSEcCtD
Glycine—Nausea—Fludarabine—lymphatic system cancer	0.00591	0.00655	CcSEcCtD
Glycine—Urticaria—Bleomycin—lymphatic system cancer	0.0058	0.00643	CcSEcCtD
Glycine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00578	0.00641	CcSEcCtD
Glycine—Hypotension—Vincristine—lymphatic system cancer	0.00568	0.0063	CcSEcCtD
Glycine—Hypotension—Mitoxantrone—lymphatic system cancer	0.00553	0.00613	CcSEcCtD
Glycine—Pain—Carmustine—lymphatic system cancer	0.00545	0.00604	CcSEcCtD
Glycine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00537	0.00596	CcSEcCtD
Glycine—Pain—Vincristine—lymphatic system cancer	0.0052	0.00576	CcSEcCtD
Glycine—Pain—Mitoxantrone—lymphatic system cancer	0.00506	0.00561	CcSEcCtD
Glycine—Urticaria—Mitoxantrone—lymphatic system cancer	0.0047	0.00521	CcSEcCtD
Glycine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00469	0.0052	CcSEcCtD
Glycine—Vomiting—Bleomycin—lymphatic system cancer	0.00464	0.00514	CcSEcCtD
Glycine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00448	0.00497	CcSEcCtD
Glycine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00436	0.00484	CcSEcCtD
Glycine—Diarrhoea—Carmustine—lymphatic system cancer	0.00436	0.00483	CcSEcCtD
Glycine—Nausea—Bleomycin—lymphatic system cancer	0.00433	0.0048	CcSEcCtD
Glycine—Dizziness—Carmustine—lymphatic system cancer	0.00421	0.00467	CcSEcCtD
Glycine—Diarrhoea—Vincristine—lymphatic system cancer	0.00416	0.00461	CcSEcCtD
Glycine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00405	0.00449	CcSEcCtD
Glycine—Vomiting—Carmustine—lymphatic system cancer	0.00405	0.00449	CcSEcCtD
Glycine—Dizziness—Vincristine—lymphatic system cancer	0.00402	0.00446	CcSEcCtD
Glycine—Visual impairment—Methotrexate—lymphatic system cancer	0.004	0.00444	CcSEcCtD
Glycine—Vomiting—Vincristine—lymphatic system cancer	0.00386	0.00429	CcSEcCtD
Glycine—Nausea—Carmustine—lymphatic system cancer	0.00378	0.00419	CcSEcCtD
Glycine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00376	0.00417	CcSEcCtD
Glycine—Chills—Methotrexate—lymphatic system cancer	0.00372	0.00413	CcSEcCtD
Glycine—Nausea—Vincristine—lymphatic system cancer	0.00361	0.004	CcSEcCtD
Glycine—Nausea—Mitoxantrone—lymphatic system cancer	0.00352	0.0039	CcSEcCtD
Glycine—Back pain—Methotrexate—lymphatic system cancer	0.0035	0.00388	CcSEcCtD
Glycine—Vision blurred—Methotrexate—lymphatic system cancer	0.00341	0.00378	CcSEcCtD
Glycine—Vertigo—Methotrexate—lymphatic system cancer	0.00325	0.0036	CcSEcCtD
Glycine—Convulsion—Methotrexate—lymphatic system cancer	0.00313	0.00347	CcSEcCtD
Glycine—Hypotension—Methotrexate—lymphatic system cancer	0.00276	0.00306	CcSEcCtD
Glycine—Pain—Methotrexate—lymphatic system cancer	0.00252	0.0028	CcSEcCtD
Glycine—Urticaria—Methotrexate—lymphatic system cancer	0.00234	0.0026	CcSEcCtD
Glycine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00217	0.00241	CcSEcCtD
Glycine—Diarrhoea—Methotrexate—lymphatic system cancer	0.00202	0.00224	CcSEcCtD
Glycine—Dizziness—Methotrexate—lymphatic system cancer	0.00195	0.00216	CcSEcCtD
Glycine—Vomiting—Methotrexate—lymphatic system cancer	0.00188	0.00208	CcSEcCtD
Glycine—Nausea—Methotrexate—lymphatic system cancer	0.00175	0.00194	CcSEcCtD
